SA
Log In
BBNX
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
8 analysts·Limited coverage
72
Score
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Rating Breakdown
Strong Buy
00%
Buy
788%
Hold
113%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$14.00
+37.0%
Consensus
$22.00
+115.3%
Bull
$25.00
+144.6%
12-Month Target Range8 analysts
$14.00$22.00$25.00
Current $10.22Consensus
Current Price
$10.22
Upside to Consensus
$11.78

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+34.99%
EPS—
FY2028
Rev+39.55%
EPS—
FY2029
Rev+20.63%
EPS—

Earnings Surprises

Recent Analyst Actions

Feb 18, 2026Lake Street
Beta Bionics price target lowered to $20 from $40 at Lake Street
Target:$20.00
+60.7%from $12.45
Feb 18, 2026Robert W. Baird
Beta Bionics price target lowered to $14 from $28 at Baird
Target:$14.00
+0.2%from $13.97
Feb 18, 2026Stifel Nicolaus
Beta Bionics price target lowered to $22 from $25 at Stifel
Target:$22.00
+57.5%from $13.97
Feb 8, 2026UBS
Beta Bionics initiated with a Buy at UBS
Target:$24.00
+83.5%from $13.08
Feb 4, 2026Stifel Nicolaus
Beta Bionics price target lowered to $25 from $31 at Stifel
Target:$25.00
+77.8%from $14.06
Feb 2, 2026Truist Financial
Beta Bionics price target lowered to $25 from $37 at Truist
Target:$25.00
+79.9%from $13.89
Jan 26, 2026Cowen & Co.
Beta Bionics initiated with a Hold at TD Cowen
Target:$17.00
+10.0%from $15.46
Jan 15, 2026Goldman Sachs
Beta Bionics price target lowered to $25 from $33 at Goldman Sachs
Target:$25.00
+47.1%from $16.99
Jan 9, 2026Lake Street
Beta Bionics price target raised to $40 from $35 at Lake Street
Target:$40.00
+88.1%from $21.26
Dec 18, 2025Truist Financial
Beta Bionics price target raised to $37 from $32 at Truist
Target:$37.00
+21.5%from $30.45
Dec 16, 2025Robert W. Baird
Beta Bionics price target raised to $28 from $23 at Baird
Target:$28.00
-5.8%from $29.73
Oct 29, 2025Lake Street
Beta Bionics price target raised to $35 from $30 at Lake Street
Target:$35.00
+44.2%from $24.28
Oct 29, 2025Stifel Nicolaus
Beta Bionics price target raised to $31 from $26 at Stifel
Target:$31.00
+27.7%from $24.28
Oct 29, 2025Goldman Sachs
Beta Bionics price target raised to $33 from $26 at Goldman Sachs
Target:$33.00
+35.9%from $24.28
Oct 29, 2025Robert W. Baird
Beta Bionics price target raised to $23 from $17 at Baird
Target:$23.00
-5.3%from $24.28
Oct 29, 2025Piper Sandler
Beta Bionics price target raised to $32 from $26 at Piper Sandler
Target:$32.00
+13.0%from $28.32
Oct 29, 2025Truist Financial
Beta Bionics, Inc. (BBNX) PT Raised to $32 at Truist Securities
Target:$32.00
+31.8%from $24.28
Oct 1, 2025Goldman Sachs
Beta Bionics upgraded to Buy from Neutral at Goldman Sachs
Target:$26.00
+30.9%from $19.87
Jul 30, 2025Robert W. Baird
Beta Bionics price target raised to $17 from $15 at Baird
Target:$17.00
+1.4%from $16.76

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance